Harriet Schellekens

Title: Harriet Schellekens: Innovator in Obesity Treatment

Introduction

Harriet Schellekens is a notable inventor based in Cork, Ireland. She has made significant contributions to the field of obesity treatment and weight management. Her innovative work focuses on a specific strain known as APC 1472, which has shown promising results in managing weight and improving metabolic health.

Latest Patents

Harriet holds a patent for treating obesity and weight management. The patent describes the strain APC 1472, which has weight-lowering effects in vivo. This is achieved by inducing satiety through decreased internalization of the Ghrelin receptor, leading to reduced constitutive activity. Additionally, the strain has demonstrated a trend towards decreased ghrelin receptor hypothalamic expression in high-fat diet-fed mice compared to the vehicle control group. The strain also improves glucose tolerance and decreases insulin plasma levels in mice, indicating its potential in the prevention and treatment of Type II diabetes, particularly in obese individuals. Harriet has 1 patent to her name.

Career Highlights

Throughout her career, Harriet has worked with esteemed institutions such as University College Cork and the Agriculture and Food Development Authority (Teagasc). Her research has been pivotal in advancing our understanding of obesity and its related health issues.

Collaborations

Harriet has collaborated with notable colleagues, including John Francis Cryan and Ted Dinan. Their combined expertise has contributed to the success of her research and innovations.

Conclusion

Harriet Schellekens is a pioneering inventor whose work in obesity treatment has the potential to make a significant impact on public health. Her innovative approach to weight management through the APC 1472 strain showcases her dedication to advancing medical science.